NEWS

The Georgia Bio Innovation Summit is the southeast’s largest life science conference, showcasing Georgia’s leadership in innovation to improve the health and well-being of people, animals and the environment. This year’s Summit will bring together hundreds of CEOs, senior executives, scientists and public policy officials from Georgia and across the nation on October 8 at the Cobb Galleria in Atlanta.

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA), the Medical Imaging & Technology Alliance (MITA) and a broad coalition of medical innovators, physician inventors, patient groups, and others sent a letter to congressional leadership today urging them to permanently repeal the medical device excise tax. “The United States is…

Gov. Brian Kemp gave a strong show of support to the Georgia Research Alliance (GRA) Thursday. But the nonprofit organization launched in 1990 with seed money from the state to grow Georgia’s technology industry still will be subject to same budget cuts Kemp has ordered for state agencies. The governor told members of the GRA board…

– Data from Nearly 2,000 Patients Finds that Men Treated with PROVENGE when Baseline PSA was <5.27 ng/mL Lived 47.7 Months – – Findings Consistent with Pivotal IMPACT Trial – September 04, 2019 01:15 PM Eastern Daylight Time SEAL BEACH, Calif.–(BUSINESS WIRE)–Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today…

100% Single-Dose Protection Observed in Lethal Challenge Model ATLANTA, GA, September 4, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its article entitled “A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge.” The paper appears in the open…

U.S. Sen. Johnny Isakson, R-Ga., announced Wednesday he will leave office early due to a battle with Parkinson’s disease.  Isakson, 74, will resign on Dec. 31 after more than 40 years in elective office at the state and federal levels.  “I am leaving a job I love because my health challenges are taking their toll on…